Explore key insights on conducting successful neurology clinical trials in Chile for innovative therapies.
Introduction In the rapidly evolving field of neurology clinical trials, Chile presents unique opportunities that demand attention from MedTech and Biopharma innovators. With its streamlined regulatory processes, notably rapid approval timelines from authorities like the Instituto de Salud Pública (ISP), and a cost-effective environment-studies can be up to 30% cheaper than in North America-Chile offers a compelling case for conducting first-in-human trials. However, organizations often struggle with patient recruitment and ethical dilemmas that can hinder trial outcomes. Without addressing these challenges, the potential benefits of conducting trials in Chile may remain untapped. Organizations must implement effective strategies to meet regulatory demands and engage diverse patient populations successfully. bioaccess®: Pioneering First-in-Human Trials in Chile’s Neurology Sector In the rapidly evolving field of neurology, the organization emerges as a leader in conducting neuro…